Form 4: Astera Labs Director Jack R. Lazar Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Director Jack R. Lazar sold shares of Astera Labs, Inc. (ALAB) on September 23, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On September 23, 2024, Jack R. Lazar, a director of Astera Labs, Inc. (ALAB), sold a total of 25,000 shares of common stock.
- The sales were executed under a Rule 10b5-1 trading plan adopted on May 22, 2024.
- The shares were sold in multiple transactions at weighted average prices of $50.7128, $50.6853, and $51.0615.
- Following the reported transactions, Lazar directly owns 140,000 shares of Astera Labs, Inc.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock sales under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This filing is a routine disclosure of insider trading activity. It is common for corporate insiders to set up 10b5-1 trading plans to sell shares over time to avoid accusations of trading on material non-public information.
Stakeholder Impact
- The stock sale by a director could have a minor negative impact on shareholder sentiment, although the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| May 22, 2024 | Date the Rule 10b5-1 trading plan was adopted by the Reporting Person |
| September 23, 2024 | Date of the stock sale transactions |
| September 25, 2024 | Date of the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.